Use of an oncolytic virus for the treatment of cancer
作者： Robert Coffin
DOI:
关键词: Agonist 、 Antagonist 、 Cancer research 、 Oncolytic virus 、 Inhibitory postsynaptic potential 、 Immune system 、 Cancer 、 Medicine
摘要: The present invention provides a method of treating cancer, which comprises administering therapeutically effective amount an oncolytic virus, inhibitor the indoleamine 2,3-dioxygenase (IDO) pathway and further antagonist immune co- inhibitory or agonist co-stimulatory to patient in need thereof.
lens.org 参考文章(47)
Robert L. Martuza, Donald M. Coen, Viral mutant HSV mediated destruction of neoplastic cells ,(1994)
Michael Curran, James Allison, Methods and Compositions for Localized Secretion of Anti-CTLA-4 Antibodies ,(2007)
Daniel P. Palermo, Fritz M. Rottman, Richard P. Woychik, Edward C. Goodwin, Leonard E. Post, Darrell R. Thomsen, Use of a bgh gdna polyadenylation signal in expression of non-bgh polypeptides in higher eukaryotic cells ,(1989)
Yakov Gluzman, Ian J. Mohr, Avirulent herpetic viruses useful as tumoricidal agents and vaccines ,(1996)
Ari Vanderwalde, Mohamed Shabooti, A method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor ,(2013)
Robert Martuza, Hiroaki Wakimoto, Samuel Rabkin, Ryuichi Kanai, Use of oncolytic herpes viruses for killing cancer stem cells ,(2009)
Larry Kaiser, Takane Toyoizumi, Katherine Molnar-Kimber, Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject ,(1999)
Robert Stuart Coffin, Herpes virus strains ,(2012)
Xinping Fu, Xiaoliu Zhang, Use of Mutant Herpes Simplex Virus-2 for Cancer Therapy ,(2006)